Psychepalooza: Advances in Knowledge and Innovative Treatments in Psychiatry and Behavioral Health
REGISTRATION IS NOW CLOSED. ON-SITE REGISTRATION WILL BE ACCEPTED.
Behavioral health providers (psychiatrists, psychologists, social workers, counselors and nursing staff) are invited to learn up-to-date knowledge of innovations in treatment. In the past several years, a number of new interventions have been developed and made available in Psychiatry and Behavioral Health. These include transcranial magnetic stimulation, biofeedback devices, intranasal esketamine, combined mother/baby treatment programs, integration of behavioral health into primary care clinics, medication assisted treatment for substance use, medical marijuana, protocols for management of concussions and traumatic head injuries, and protocols for appropriate use of medications in children and adolescents.
All of our current and past trainees and faculty, and their guests, are invited to a dinner reception at the Grand Hall at the Priory that Friday evening, from 6-10 pm. There will be a $75/person cost. RSVP to Cindy DeLuca at firstname.lastname@example.org by 9/7/19 to attend the dinner reception!
- Identify the benefits of integrating behavioral health into primary and specialty care settings, and describe relevant clinical, legal, documentation, and consultation issues.
- Describe the scientific rationale and side effects and contraindications, and appraise efficacy data for use of TMS and esketamine in MOD
- Describe the cognitive symptoms associated with concussions, and list appropriate assessment tools and appraise the evidence regarding appropriate intervention strategies
- Identify innovative strategies to help new mothers with mental health problems to engage in behavioral health treatment and to appraise the evidence base for successful treatment.
- Describe scientific rationale for use of esketamine in MDD, describe side effects and contraindications, and appraise efficacy data
- Describe the scientific rationale and appraise the evidence base for a biofeedback device for symptoms of anxiety and panic disorder
- List effective medication assisted treatment strategies and analyze the evidence based supporting initiation of such strategies in combination with therapy for patients with substance use disorders, and describe and analyze the evidence base for medical marijuana use in patients with mental health problems
- 6.50 AMA PRA Category 1 Credit™
- 6.50 APA
- 6.50 Attendance